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Genome-wide association study 
and whole-genome sequencing 
identify a deletion in LRIT3 
associated with canine congenital 
stationary night blindness
Rueben G. Das 1, Doreen Becker  1,2, Vidhya Jagannathan3, orly Goldstein4, 
evelyn Santana1, Kendall carlin1, Raghavi Sudharsan1, tosso Leeb  3, Yuji nishizawa5, 
Mineo Kondo6, Gustavo D. Aguirre1 & Keiko Miyadera1
congenital stationary night blindness (cSnB), in the complete form, is caused by dysfunctions in 
ON-bipolar cells (ON-BCs) which are secondary neurons of the retina. We describe the first disease 
causative variant associated with CSNB in the dog. A genome-wide association study using 12 
cases and 11 controls from a research colony determined a 4.6 Mb locus on canine chromosome 32. 
Subsequent whole-genome sequencing identified a 1 bp deletion in LRIT3 segregating with cSnB. 
the canine mutant LRIT3 gives rise to a truncated protein with unaltered subcellular expression in 
vitro. Genetic variants in LRIT3 have been associated with cSnB in patients although there is limited 
evidence regarding its apparently critical function in the mGluR6 pathway in ON-BCs. We determine 
that in the canine CSNB retina, the mutant LRIT3 is correctly localized to the region correlating with the 
on-Bc dendritic tips, albeit with reduced immunolabelling. the LRIT3-cSnB canine model has direct 
translational potential enabling studies to help understand the cSnB pathogenesis as well as to develop 
new therapies targeting the secondary neurons of the retina.
Our ability to visually perceive the surrounding environment is a result of the concerted action of multiple spe-
cialized cell types in the retina. Photoreceptors are the photosensitive cells in the retina, consisting of rods respon-
sible for vision in dim light, and cones that aid in colour perception and vision under bright light. Once the 
photoreceptors capture light energy, the information is converted into neural signals that are relayed to multiple 
types of bipolar cells (BCs) that in turn transmit the signal to tertiary retinal neurons such as amacrine and 
retinal ganglion cells, before being transmitted to the visual cortex. Based on their ability to either initiate or ter-
minate light stimuli BCs can be either ON- or OFF-type. While cone photoreceptors can connect both ON- and 
OFF-BCs, the rods are served largely by the ON-BCs1,2.
Congenital stationary night blindness (CSNB) is a clinically and genetically heterogeneous, non-progressive 
disease that can occur due to genetic defects in retinoid metabolism in the retinal pigment epithelium (RPE), 
defects in photoreceptor phototransduction, or signal transmission through the ON-BCs3. Affected individu-
als exhibit non-progressive dark or dim-light visual difficulties (nyctalopia) starting from birth. However, these 
symptoms might be missed more often in the well-lit urban environment. Currently there is no cure for the 
disease. Based on the electroretinogram (ERG) patterns, CSNB can be clinically sub-classified as Riggs and 
Schubert-Bornschein forms. The a-wave and overall ERG amplitude are reduced, but the waveform is preserved, 
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in the Riggs form due to defects in the photoreceptors4, and is linked to variants in genes underlying proteins 
involved in rod phototransduction. It has both autosomal dominant (RHO, PDE6B and GNAT1) and recessive 
(SLC24A1 and GNAT1) inheritance5–10. The Schubert-Bornschein type has a “negative-type” ERG with a nor-
mal amplitude a-wave and a significantly reduced b-wave due to defective signalling from photoreceptors to 
the BCs11. In the incomplete form (incomplete CSNB), the signal transmission from photoreceptors to BCs is 
partially blocked and affects both the ON- and OFF-pathways, so patients have reduced but recordable residual 
rod function12. Genetic variants in CACNA1F13,14, CABP415 and CACNA2D416, which are all expressed in the 
photoreceptor synaptic terminals, can lead to incomplete CSNB. Finally, a dramatically reduced b-wave in the 
Schubert-Bornschein type is due to defects in the ON-BC pathway, resulting in complete CSNB. The mGluR6 
receptor on ON-BCs detects decreased levels of glutamate released by photoreceptors in response to light, and 
the consequent deactivation of a G protein signalling cascade results in the closure of the TRPM1 cation channel, 
thereby evoking depolarization (activation) of ON-BCs. The loss of ERG b-wave in complete CSNB corresponds 
to the loss of this ON-BC depolarization. Genetic variants that can cause complete CSNB have been found in 
NYX17,18, GRM619, TRPM120,21, GPR17922,23, and LRIT324, whose protein products all localize to the dendritic tips 
of the ON-BCs.
Model organisms are important for both basic and translational research, as they provide critical clues not 
only for a better understanding of the disease and its mechanism, but are also used to develop new therapies. 
A series of transgenic mouse models of complete CSNB (also known as the no b-wave (nob) mice) have been 
developed including Nyxnob1 25, Cacna1fnob2 26, Grm6TmlNak 27, Grm6nob3 28, Grm6nob4 29, Gpr179nob5 30, and Lrit3nob6 31. 
Further, spontaneously-occurring mouse models such as Grm6nob7 32, Grm6nob8 33 and Lrit3tvrm257 34 have also been 
described. Naturally-occurring complete CSNB has also been reported in Appaloosa horses and at least two other 
equine breeds with a white spotting phenotype (leopard complex spotting)35 which have a homozygous 1378-bp 
retroviral insertion in intron 1 of TRPM136.
We have previously reported the first naturally-occurring canine model of complete CSNB with an autosomal 
recessive mode of inheritance segregating in a research colony of Beagle dogs37. Herein we report a genome-wide 
association study (GWAS) which, together with whole-genome sequencing (WGS) performed in parallel, iden-
tified an association between canine CSNB and a truncating single base deletion in LRIT3, a gene that has previ-
ously been associated with CSNB in mice and people. Of the 30+ canine inherited retinal disease models whose 
causative genetic variants have been identified to date, the clinically-relevant canine LRIT3-CSNB is the only 
model with ON-BC defects and therefore carries unique translational potential in therapeutic targeting of these 
secondary retinal neurons.
Results
GWAS mapping of a 4.6 Mb locus on CFA32 associated with canine CSNB. GWAS was performed 
using DNA samples from 12 CSNB and 11 control animals from a canine research colony (Fig. 1). Note that all the 
controls available were obligate carriers as a result of an intentional breeding strategy aimed at producing CSNB 
affected dogs. After pruning the single-nucleotide variant (SNV) chip data for low genotyping rate and low minor 
allele frequency, we identified a single strong hit on canine chromosome 32 (CFA32) with a corrected p-value of 
1.81 × 10−6 (Fig. 2a). The quantile-quantile plot of observed versus expected p-values of the mixed model analysis 
also supported the effectiveness of the correction for population structure and the significance of the CFA32 locus 
(Fig. 2b). Of the 2,908 SNVs on the genotyping chip designed to cover CFA32, there were 2,135 SNVs that proved 
to be informative using the above sample population. The top 10 SNVs with the highest association achieving 
a corrected p-value of ≤5.75 × 10−5 resided on CFA32 between 22,654,843 and 28,799,548 bp. Since the CSNB 
allele was introduced in the research colony by a common founder, we hypothesized that the affected animals 
would be identical by descent (IBD) for the causative genetic variant as well as for the flanking chromosomal 
segments. Therefore, homozygosity mapping was performed on CSNB cases to search for extended regions of 
homozygosity with simultaneous allele sharing on CFA32. Consequently, we identified a single chromosomal 
region of homozygosity spanning 4.6 Mb (CFA32: 27,752,177-32,306,733) (Fig. 3a; Supplementary Fig. 1).
Identification of a 1 bp deletion in LRIT3 by WGS. To comprehensively screen for variants across the 
critical interval, as well as for surveying the entire genome for chromosomal segments and pathogenic genetic 
variants that could not be identified by the SNV-chip based approach, WGS was carried out. Paired-end reads 
(2 × 100 bp) were collected from a shotgun DNA fragment library from two CSNB affected and two carrier ani-
mals (European Nucleotide Archive accession # ERS3011607-#ERS3011610), achieving genome-wide cover-
ages of 13 × −20x for each sample. Single nucleotide and indel variants were called against the canine reference 
genome (CanFam3.1). The variants in the two CSNB cases were filtered against the genomes of the two carriers as 
well as 271 dogs from 75 different breeds in which CSNB was not known to segregate, and had been sequenced for 
unrelated studies (Supplementary Table 1). We hypothesized that the causative variant should be homozygous in 
the CSNB cases, heterozygous in the carriers, and absent in the control dogs of other breeds. After a genome-wide 
filtering of variants, a single variant with the strongest predicted pathogenic effect fitting these characteristics was 
identified; a 1 bp homozygous deletion (CFA32: 30,038,862_30,038,863delG) in LRIT3 (Fig. 3b,c; Supplementary 
Fig. 2). This variant was expected to cause a frameshift with early protein truncation (p.249*) (Fig. 3d) in both 
LRIT3 isoforms (681 aa. and 493 aa.) (Supplementary Information 1) expressed in the retina. Genotyping of DNA 
samples of all the research dogs available from the CSNB pedigree confirmed that this deletion was in complete 
concordance with the CSNB disease status clinically assessed by ERG (Fig. 1). Further, we have confirmed com-
plete co-segregation of the LRIT3 variant with CSNB in a more recently developed satellite research colony of 39 
additional dogs (Supplementary Fig. 3) originating from 3 of the affected dogs in the original research colony 
used for GWAS.
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In a previous study, we excluded LRIT3 from causal association with CSNB through haplotype analysis based 
on 13 informative genetic markers (11 intragenic and 2 flanking) identified across the genomic region of LRIT337. 
However, this approach failed to identify the disease association of LRIT3 due to its inability to differentiate the 
disease chromosome (Adel) from one of the non-disease chromosomes (AWT). This is likely due to a-limited num-
ber of markers used, and b-minimal difference in marker pattern between chromosomes Adel and AWT due to the 
relatively recent emergence of the disease variant. Further, in the same study, we had described the exclusion of 
exonic sequence variants in LRIT3 based on Sanger sequencing37. Upon careful re-examination of experimen-
tal records, we determined a critical misidentification of samples interfering with the correct interpretation of 
the sequencing results. Once the appropriate sample was assigned, the LRIT3 homozygous deletion (CFA32: 
30,038,862_30,038,863delG) identified by WGS in the current study was indeed confirmed to segregate com-
pletely with CSNB.
Figure 1. Segregation of CSNB in the canine research colony and association with the haplotype harboring 
the LRIT3 variant. The pedigree of the canine research colony segregating the autosomal recessive CSNB 
phenotype. The symbols for the animals included in the GWAS are outlined in bold red (cases) and blue (control 
carriers). The diploid haplotype spanning the canine LRIT3 genomic region is shown under each symbol or 
animal ID in all animals whose DNA sample was available. The details of the three existing haplotypes defined 
by informative SNV markers are shown in the right side of the figure along with their chromosomal locations. 
Two haplotypes AWT (orange block) and B (light blue block) were identified initially. Subsequent fine mapping 
of the region using whole-genome sequencing identified additional sequence variants including a 1 bp deletion 
highlighted in red (chr32:30,038,863; CanFam3.1), defining a third haplotype Adel. The 1 bp deletion in LRIT3 
segregated completely with the CSNB phenotype.
Figure 2. Mapping of canine CSNB by genome‐wide association study. (a) Genome-wide association plot 
using 12 CSNB cases, and 11 obligate carriers as controls. Note the association signal on canine chromosome 32 
(CFA32). (b) The quantile–quantile (QQ) plot shows the observed vs expected -log P values. The straight line 
in the QQ plot indicates the distribution of SNV markers under the null hypothesis, and the skew at the right 
edge indicates those markers that are more strongly associated with the trait than would be expected by chance. 
Markers from CFA32 are shown in red.
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The canine LRIT3 is predicted to have a signal peptide, two LRR (Leucine-rich repeats), two LRR type 
domains, and one each of LRRCT (LRR C-terminal), IGc2, FN3, and transmembrane domains. The truncated 
protein is predicted to lack the IGc2, FN3, and the C-terminal transmembrane domains (Fig. 3e). Comparative 
amino acid sequence alignment of LRIT3 across species showed that the four altered amino acids before the 
premature stop codon in the canine mutant are well conserved across the different species examined, with only 
minor variations found in platypus and zebrafish (Fig. 3d).
RnA-seq data reveal the expression of the mutant LRIT3 transcript and unremarkable expres-
sion profile of genes in the mGluR6 pathway. In mammalian cells, transcripts containing premature 
stop codons are generally degraded by nonsense-mediated decay (NMD). The efficiency, however, depends on 
the position of the premature stop codon38. To examine if the genetic variant in LRIT3 promotes NMD, we uti-
lized RNA-seq data obtained from CSNB, carrier and WT retinal samples (n = 3 each). These 75 bp single-end 
RNA-seq data were also utilized to assess differential expression of genes across the retinal transcriptome. When 
individual bam files were visualized using the Integrative Genomics Viewer (IGV), the alignments represented 
full-length LRIT3 transcripts in WT, carrier, and CSNB samples (Supplementary Fig. 2A), indicating that the 
mutant transcript with the premature stop codon escapes NMD. Transcriptome-wide analysis did not reveal any 
retinal expressed genes to be differentially expressed between WT, carrier, and CSNB. This included LRIT3 and 
other genes in the mGluR6 pathway (Supplementary Fig. 4A). At the protein level, TRPM1, the critical chan-
nel protein of the mGluR6 pathway and localized by LRIT3, was expressed similarly in WT, carrier, and CSNB 
(Supplementary Fig. 4B). These findings suggest that the disease was impacted specifically by the loss of function 
of the mutated LRIT3.
Experimental identification of the canine LRIT3 transcript sequence and its isoform. The canine 
LRIT3 cDNA sequence was derived from our canine retinal RNA-seq data and was confirmed to consist of four 
exons. This differed from the NCBI prediction that lacked the first, non-coding exon, as well as from the Ensembl 
prediction (ENSCAFT00000018278.3; accessed 11/21/2018) that lacked a larger portion of the 5′ exon, thereby 
predicting truncation of the 5′ end of the transcript. The experimentally confirmed canine LRIT3 cDNA sequence 
is shown in Supplementary Information 1. Based on the revised canine LRIT3 transcript sequence, primers were 
designed to clone the full coding sequence of canine LRIT3. RT-PCR yielded the full-length transcript (2,080 bp) 
Figure 3. The mapped CSNB interval and the genetic variant in LRIT3 leading to a premature stop codon. 
(a) The 4.6 Mb mapped CSNB interval (shaded in orange) in canine chromosome 32 (CFA32) shown with 
the 22 genes localized in the region. (b) The 1 bp deletion is located in exon 3 of LRIT3. (c) Representative 
chromatograms showing the c.762_763delG variant in heterozygous and homozygous states in the carrier and 
CSNB, respectively, while it is absent in WT. (d) Alignment of LRIT3 across different species indicating high 
evolutionary conservation of the immunoglobulin c2 type (IGc2) domain where the 1 bp deletion was identified 
(highlighted in yellow). The sequences used for alignment are: XP_005156597.2 (Zebra fish), XP_007668336.1 
(Platypus), XP_007496058.1 (Opossum), AHI87499.1 (Mouse), NP_001178443.1 (Cow), XP_005555723.1 
(Monkey), AAI04038.1 (Human), XP_001139031.3 (Chimp), XP_853150.3 (Dog) and XP_003985132.1 (Cat). 
(e) Domains of canine LRIT3 as predicted by Scan Prosite (https://prosite.expasy.org). The red arrow indicates 
the location of the deletion. SP, signal peptide; LRR, leucine rich repeat; LRR_TYP, LRR type; LRRCT, LRR 
C-terminal; IGc2, immunoglobulin c2 type; FN3, fibronctin type 3; TM, transmembrane.
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as well as a smaller, less abundant product (1,607 bp) (Fig. 4a). Both products were gel-purified and Sanger 
sequenced. Alignment of the two sequences revealed a splicing event in which exon 2, consisting of 473 bp, had 
been spliced out in the shorter product, confirming the presence of two LRIT3 isoforms in canine retina. As the 
larger, full-length transcript was predominant among the transcripts and contained all the elements, subsequent 
functional studies were carried out using this 2,080 bp transcript.
Comparable subcellular localization between WT and mutant canine LRIT3. To examine the 
subcellular localization of the expressed LRIT3 protein and determine if the mutant protein was trapped in the 
endoplasmic reticulum (ER) or Golgi, WT and mutant canine LRIT3 cDNA were each cloned into expression 
vectors with N-terminal Myc tags, and overexpressed in mammalian cultured cells, COS1 and 661 W. Transfected 
cells were either harvested for protein extraction and used for Western blot or fixed with 20% paraformaldehyde 
for immunocytochemistry. Immunoblotting with anti-Myc showed the expected 75 kD band in the WT while 
a truncated fragment just above the size of 25 kD was found for the mutant LRIT3 (predicted to lack the IGc2, 
FN3, and C-terminal transmembrane domains and having a molecular weight of 29 kD) (Fig. 4b). Therefore, 
we experimentally confirmed that the stop codon introduced by the deletion in LRIT3 gave rise to a truncated 
protein while escaping NMD. Immunocytochemistry in COS1 cells did not find notable differences in subcellular 
localizations between WT and mutant LRIT3. Co-immunolabelling with cellular markers indicated no abnormal 
retention of the mutant protein in the ER or Golgi (Supplementary Fig. 5).
Reduced punctate LRIT3 immunolabelling in the OPL of canine CSNB. We have previously carried 
out a detailed IHC to determine if retinal morphology and localization of relevant proteins are affected in CSNB37. 
In that study, our IHC conditions used did not allow effective immunolabelling of retinal cryosections with the 
anti-LRIT3 antibody. To this end, we have modified the antigen retrieval method for IHC and now can detect dis-
tinct punctate immunolabelling in the outer half of the OPL in the WT retina (Fig. 5a). When co-immunolabelled 
with Goα, these puncta were localized to the region correlating with the rod and cone ON-BC dendritic tips. 
While intense punctate immunolabelling was found in the WT retinas, the labelling was less intense in the carrier 
and markedly reduced in CSNB retinas (Fig. 5a). Further, while the number of puncta was comparable between 
the WT and carrier retinas, the CSNB retina had reduced (<1/3rd) punctate labelling (Fig. 5b), and had less strin-
gent localization of specific LRIT3 labelling to the region correlating with the dendritic tips. These observations 
are expected given that the commercial anti-LRIT3 antibody has reduced epitope matching with the truncated 
mutant LRIT3 (55 amino acids) in contrast to the WT LRIT3 (141 amino acids). Notably, as we have shown pre-
viously, immunolabelling of PKCα is altered in the CSNB retina where there was reduced labelling intensity in 
the somata37 as well as in the dendrites (Supplementary Fig. 6). These findings are compatible with the functional 
defect of the mGluR6 pathway taking place in the ON-BC dendrites of CSNB retinas.
Altered peanut agglutinin (pnA) labelling along the opL of canine cSnB. PNA is a marker that 
labels the insoluble extracellular matrix surrounding cone photoreceptor outer and inner segments as well as 
the synaptic cleft39–41. To determine if there are PNA labelling abnormalities at the OPL level42, we examined the 
PNA labelling pattern in WT, carrier and CSNB canine retinas, counterstained with the ON-BC marker Goα 
(Fig. 6a,b). In the WT canine retina we found organized clusters of intense PNA labelling aligned horizontally 
along the OPL, and overlapping with the ON-BC dendritic tips (Fig. 6b). In contrast, the CSNB retina had fewer, 
less intense, and disorganized PNA labelling along the OPL. The carrier retina seemed to retain the horizontal 
organization of the PNA labelling. These findings indicate that the architecture of the cones and the contacting 
ON-BCs is distorted and that the synaptic conformation is altered in the CSNB retina.
Figure 4. WT canine LRIT3 transcripts and expression of WT and mutant canine LRIT3 proteins. (a) RT-PCR 
showing the presence of full-length LRIT3 (large arrow head) as well as a shorter and significantly less abundant 
second isoform (small arrow head) in the WT canine retina. NTC, no template control. (b) Western blot 
showing expression of the expected full product (75 kD) with WT LRIT3 while the mutant LRIT3p.249* show 
expression of a truncated protein (29 kD) and lack of the full product. Images of the complete gel (a) and blot 
(b) are included in Supplementary Fig. 7.
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comparable ultrastructure of photoreceptor to on-Bc synapses between Wt and cSnB canine 
retinas. To examine if the synaptic contacts of invaginating ON-BC dendrites were altered43, we examined 
the ultrastructure of WT and CSNB canine retinas by transmission electron microscopy. We found that both 
cone pedicles and rod spherules were formed and localized normally in the affected canine retina, consistent 
with the observation by others in the Lrit3nob6/nob6 mouse43. We also found that the invaginating ON-BCs formed 
triads across the cone and rod populations with no significant difference between WT and mutant canine retinas 
(Fig. 7a). This is in contrast to the Lrit3nob6/nob6 mouse that was found to have decreased triads in the cone pedi-
cles43. In addition, we found no notable differences with the OFF-BC contacts between WT and mutant canine 
retinas. To quantitate the contact elements, we identified 76 and 83 rods spherules, and 23 and 46 cone pedicles 
in non-overlapping sections from WT and CSNB canine retinas, respectively, and demonstrated that the distri-
bution of triads and diads was comparable between WT and CSNB canine retinas for both rods (p = 0.68) and 
cones (p = 0.90) (Fig. 7b).
Discussion
We have previously characterized an autosomal recessive form of complete CSNB in a research colony of Beagle 
dogs, and excluded the functional candidate genes from disease association37. In the present study, we carried 
out a GWAS to map the disease locus, followed by WGS which led to the identification of a single base deletion 
(c.762_763delG) in LRIT3, one of the genes previously excluded. That exclusion was based on haplotype analysis 
using 13 informative genetic markers (11 intragenic and 2 flanking) across LRIT3, as well as Sanger sequencing 
of exons37. We have now confirmed that the haplotype analysis was unable to detect the disease association with 
LRIT3 due to insufficient marker density. Further, we have determined that there was a critical sample misiden-
tification in the previous study leading to the LRIT3 variant (CFA32: 30,038,862_30,038,863delG) being disre-
garded from association. Typing of the LRIT3 variant in all available dogs in the CSNB research colony as well as 
in a more recently developed satellite colony confirmed complete co-segregation of the LRIT3 variant with the 
CSNB phenotype. Furthermore, the variant was not present in any of the 271 control dogs representing 75 breeds 
derived from the Dog Biomedical Variant Database Consortium.
The CSNB-associated variant identified in LRIT3 introduces a premature stop codon in LRIT3 (p.249*). 
RNA-seq shows the presence of full-length LRIT3 mRNA in the mutant retina, suggesting escape from NMD. 
Cloning and in vitro expression of the mutant LRIT3 demonstrated the presence of a truncated protein of approx-
imately 29 kD. In vitro cellular expression pattern was comparable between WT and mutant LRIT3 with no evi-
dence of entrapment of mutant protein in the ER or Golgi. We would note that while the in vitro studies provide 
an opportunity to test such hypotheses, overexpression in undifferentiated cultured cells that are not ON-BC can 
cause departure from the natural expression patterns, and hence caution is required upon interpretation of the 
data.
Figure 5. Decreased LRIT3 immunolabelling in the region correlating with the ON-BC dendritic tips in 
the LRIT3del/del CSNB retina. (a1) Representative confocal microscopy images of canine retinal cryosections 
showing distinct LRIT3 puncta immunolabelling in the region correlating with the dendritic tips of ON-BCs 
(labelled with anti-Goα antibody) in WT and carrier retinas. In the CSNB canine retina, these signals are 
decreased in intensity and numbers (see B). The lower panels are magnified images of the ON-BC dendrites. 
Scale bar, 10 µm. (a2) High magnification of the OPL in the CSNB retina from (a1) to display the punctal 
labelling (arrows) in the region correlating with to the ON-BC dendritic tips. Scale bar, 10 µm. (b) The number 
of LRIT3-labelled puncta in the region correlating with the ON-BC dendritic tips was counted in retinal 
sections co-labelled with anti-LRIT3 and Goα antibodies. While the WT and carrier retinas showed comparable 
number of puncta, the number was markedly reduced in the CSNB retina (<1/3 of WT and carrier). Note that 
statistical analysis could not be performed due to small sample sizes. Error bars represent the range of counts.
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At the retinal level, IHC showed specific localization of anti-LRIT3 immunolabelling in the region correlat-
ing with the ON-BC dendritic tips of the controls retinas, while the LRIT3 signal was reduced in intensity and 
number in the CSNB retinas. It is important to note that the commercial anti-LRIT3 antibody utilized recognized 
a 141 amino-acid epitope that spanned the site of the 1 bp deletion and protein truncation. As a result, only the 
N-terminus 37% (52/141 amino acids) of the epitope was present in the mutant LRIT3 followed by 4 aberrant 
amino acids before the stop codon. Further to the partial loss of epitopes recognized by the antibody, the smaller 
size of the truncated mutant LRIT3 could be contributing to the reduced LRIT3 signal in IHC. Finally, the altered 
immunolabelling of rod ON-BC dendrites with anti-PKCα supports the basis for ON-BC dysfunction observed 
clinically as well as electroretinographically. As the mutant LRIT3 lacks the IgC2, serine-rich FN3 and trans-
membrane domains, further investigation of the functional consequences of these deficits at the molecular level 
will shed light on the poorly understood role and interacting partners of LRIT3 within the mGluR6 pathway. For 
example, LRIT3 is thought to play a supportive role in the ability of nyctalopin to localize TRPM1 to the dendritic 
tips of BCs42,44. In support, the Lrit3-deficient nob6 mice lack most of the post-synaptic clustering of mGluR6 
pathway components, although this abnormality is limited to cone ON-BCs42. More recent TEM data suggest that 
LRIT3 might be involved in the coordination of the trans-synaptic communication between cones and ON-BCs 
during synapse formation and function43. In the LRIT3-CSNB canine retina, we found that mGluR6 pathway 
components were still present, although they were less abundant compared to the WT37. In the current study, we 
find attenuated PNA labelling along the OPL in canine CSNB as was found in the Lrit3 mutant mouse43. However, 
contrary to findings in the Lrit3 mutant mouse, ultrastructural abnormalities specific to the cone synapses are not 
Figure 6. Altered PNA staining in the OPL of the CSNB retina. (a) Cryosections of WT, carrier and CSNB 
affected canine retinas co-labelled with anti-Goα antibody (red) and PNA (green). The organized PNA 
labelling present along the OPL was evident in WT and carrier retinas but not in the CSNB retina. There was 
no significant difference in the PNA labelling pattern associated with the cone outer segment across the three 
sample groups. (b) Magnified images of the OPL outlined in (a) are shown. Distinct staining with PNA is 
horizontally organized along the ON-BC dendritic tips in the WT retina. Similar pattern, albeit slightly less 
intense, is present in the carrier retina, but is minimal in the CSNB retina. Scale bar, 10 μm.
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found in the canine CSNB retina indicating differences in pathogenesis presumably affected by the type of LRIT3 
disease variant (i.e. partial C-terminus truncation in the canine mutant or complete deficiency in the knockout 
murine model).
While this manuscript was under review, Hasan et al. published a study in the mouse retina proposing a 
transsynaptic role of LRIT345. They demonstrated by in situ hybridization that LRIT3 is expressed rather pre-
synaptically in the rod photoreceptor terminals and acts transsynaptically to localize the TRPM1 channel in the 
postsynaptic bipolar cells. Further, they showed ERG recovery in knockout mice when LRIT3 expression was 
restored in the rods via AAV delivery. The resolution of IHC used, however, was insufficient to allow differen-
tiation between pre- and post-synaptic localization of LRIT3 which appeared to ‘colocalize’ with mGluR6 and 
TRPM1 in the mouse retina. Studies are underway to verify LRIT3 localization in the canine retina to identify 
the therapeutic target cells for reversing the CSNB phenotype. In summary, we have identified a single base dele-
tion in LRIT3 associated with complete CSNB in the canine model. The mutant LRIT3 transcript escapes NMD 
and gives rise to a truncated protein that shows unaltered subcellular expression in cultured cells in vitro. In the 
canine CSNB retina, immunolabelling of LRIT3 correlating to the ON-BC dendritic tips is altered with reduction 
in intensity and quantity, and there is altered immunolabelling of rod ON-BC dendrites. Future studies aim to 
elucidate the molecular pathogenesis as well as to test therapeutic targeting to restore ON-BC function.
Materials and Methods
ethics statement. The research was conducted in full compliance and strict accordance with the Association 
for Research in Vision and Ophthalmology (ARVO) Resolution on the Use of Animals in Ophthalmic and Vision 
Research. The protocol was approved by the Institutional Animal Care and Use Committees (IACUCs) of Mie 
University Graduate School of Medicine (#24–49) and the University of Pennsylvania (#801870). Even though 
none of the procedures used were expected to cause pain to the study subjects, every effort was made to eliminate 
potential discomfort.
Animals, genome-wide association study, and homozygosity mapping. Genomic DNA samples 
from a subset of Beagle dogs from a canine research colony described previously37 – 12 CSNB cases (10 females, 
2 males) and 11 obligate carriers (3 females, 8 males) were genotyped on the Illumina CanineHD BeadChip 
(Illumina, San Diego, CA) containing 173,662 SNV markers. The data were subjected to standard quality con-
trol, where SNVs were excluded for poor genotyping rates (<95%) and low minor allele frequencies (<0.01). 
Population stratification, resulting from close familial relationships, was confirmed by the genomic inflation 
factor of 1.55 calculated during an association test. Therefore, a mixed model approach utilizing the GenABEL 
package46 was applied for the association analysis to correct for this population stratification and any cryptic 
relatedness. This correction resulted in a genomic inflation factor of 1.04. To identify extended homozygous 
regions with allele sharing across all affected animals using the software PLINK v1.0747 (http://pngu.mgh.har-
vard.edu/purcell/plink/), the options–homozyg-group and–homozyg-match were applied. Haplotypes around 
the significantly associated locus were constructed using PHASE48. The final critical interval was defined by visual 
Figure 7. Comparable ultrastructure of rod and cone synapses in WT and CSNB canine retina. (a) 
Ultrastructure of rod and cone synapses in WT and CSNB canine retinas. Representative transmission electron 
microscopy images are shown for rod and cone ribbon synapses. Invaginating dendrites (pink) of both rod 
and cone ON-BCs, and horizontal cell processes (blue) are illustrated. Scale bar, 500 nm. (b) Quantification of 
synaptic elements identified in rod spherules and cone pedicles for each WT and CSNB canine retina. Data is 
shown as the ratio (%) of diads and triads for each rod and cone synapses in which the number of diads and 
triads were counted. Synapses were classified as diads if they have identifiable ribbon with adjacent horizontal 
cell process (blue). If there is additional ON-BC process (pink) next to the synaptic ribbon, they were designated 
as triads.
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inspection of all SNV chip genotypes of the cases on canine chromosome 32 in an Excel-file. All genome positions 
refer to the CanFam3.1 reference sequence assembly.
In addition to the dogs from the original colony37, 39 dogs from a newly developed sattellite colony were 
included for the genotype-phenotype segregation analysis. The founder of this satellite colony included 3 animals 
from the original colony (Supplementary Fig. 3). Additional founders included Beagle dogs obtained from a com-
mercial laboratory animal vendor and that were identified as carriers or affected for CSNB.
Whole-genome sequencing and variant calling. Genomic DNA fragment library with a 250 bp insert 
size was prepared from two CSNB affected (1 female, 1 male) and two obligate carriers (1 female, 1 male) using 
an Illumina TruSeq PCR-free DNA Library Preparation Kit. Whole-genome sequencing was carried out using 
the HiSeq. 2500 instrument (Illumina, San Diego, CA). The number of paired-end reads (2 × 100 bp) for each 
of the four samples were 120, 172, 230, and 239 million reads corresponding to a mean mapped read coverage 
of 14.59, 20.82, 27.89 and 28.96 times depth, respectively. The reads were mapped to the dog reference genome 
(CanFam3.1) using the Burrows-Wheeler Aligner (BWA) version 0.7.5a49 with default settings. The Picard tools 
(http://sourceforge.net/projects/picard/) were used to sort the mapped reads by the sequence coordinates and to 
label the PCR duplicates. The Genome Analysis Tool Kit (GATK version v3.6)50 was used to perform local indel 
realignment followed by base quality recalibration (BQSR). Finally, single-nucleotide variants (SNVs) and indels 
were called using the GATK 2-step process using ‘HaplotypeCaller’ and ‘GenotypeGVCFs’. GenotypeGVCFs was 
run per-chromosome (combined afterward using GATK ‘CatVariants’). Variant data was obtained in variant call 
format (version 4.0) as raw calls for all samples and sites flagged using the variant filtration module of GATK. 
Variant calls that failed to pass the following filters were labelled accordingly in the call set: (i) Hard to Validate 
MQ0 ≥ 4 & ((MQ0/(1.0 * DP)) > 0.1); (ii) strand bias (low Quality scores) QUAL < 30.0||(Quality by depth) 
QD < 5.0||(homopolymer runs) HRun > 5||(strand bias) SB > 0.00; (iii) SNP cluster window size 10. The snpEFF 
software51 together with the CanFam 3.1 annotation was used to predict the functional effects of detected vari-
ants. We considered the following snpEFF categories of variants as non-synonymous: non_synonymous_coding, 
codon_deletion, codon_insertion, codon_change_plus_codon_deletion, codon_change_plus_codon_inser-
tion, frame_shift, exon_deleted, start_gained, start_lost, stop_gained, stop_lost, splice_site_acceptor, splice_
site_donor. The critical interval on chromosome 32 contained 4,554,556 bases with a depth average of 21.6. The 
sequence data from the CSNB cases and carriers were compared to the Boxer reference genome (CanFam3.1) and 
whole-genome sequencing data from 271 dogs not known to be affected with CSNB representing 75 breeds in the 
Dog Biomedical Variant Database Consortium (University of Bern, Zurich) (Supplementary Table 1).
tissue collection, RnA and protein isolation. Whole retinas were isolated from the posterior eyecups 
of three CSNB affected (females; age 13-25 mon), three carrier (females, age; 13–25 mon), and three WT (1 male, 
2 females; age 7–14 mon) animals following immediate collection of the globes after humane euthanasia, flash 
frozen in liquid nitrogen, and stored at −80 °C. RNA was extracted from retinal tissues using conventional Trizol 
method followed by DNase I treatment (Ambion, Carlsbad, CA). Total protein was extracted from the retina of 
the fellow eyes of the same group of CSNB and carrier animals as well as 3 other WT controls (1 male, 2 females; 
age 7–25 mon) using T-PER™ reagent (Thermo Fisher Scientific, Waltham, MA) with 1% protease and phos-
phatase inhibitor cocktail (Thermo Fisher Scientific, Waltham, MA).
canine retinal library preparation, RnA-seq data generation, sequence alignment, abundance 
estimation, data normalization, and data visualization. Retinal samples of three each CSNB, car-
rier, and WT control animals described under tissue collection were used for RNA-seq. Prior to cDNA library 
preparation, RNA integrity number (RIN) was assessed using 2100 bioanalyzer (Agilent, Santa Clara, CA) 
to determine the quality of the RNA. Poly(A) + -enriched cDNA libraries were generated using the TruSeq 
Sample Preparation kit (Illumina) and checked for quality and quantity using the bioanalyzer and qPCR (KAPA 
Biosystems, Wilmington, MA). Single-end reads (76 bp) were obtained using the Illumina HiSeq. 1500 platform. 
Trimmomatic52 was used to remove any remaining Illumina adapter sequences from reads and to trim bases off 
the start or the end of a read when the quality score fell below a threshold of 20. Sequence quality metrics were 
assessed using FastQC (www.bioinformatics.babraham.ac.uk/projects/fastqc/). Sequence reads were aligned to 
the canine reference genome (CanFam3.1) using STAR53. The abundance of reads mapping to each gene feature 
in the aligned genome was determined using HTSeq54. Non-expressed and weakly expressed genes, defined as 
having less than 1 read per million in the three samples per group were removed for further analysis. A correla-
tion plot was generated to determine the correlation between technical replicates. The technical replicates of each 
sample were then merged into one file. This was followed by counting the number of genes and quality assessment 
using RseqC55. Sequences aligned with the canine reference genome were visualized using the IGV program.
Global data assessment and differential expression analysis of RNA-seq data. Quantile normal-
ization was applied to all samples56 and data were log2-transformed. To evaluate replicates and visualize the rela-
tionships between samples, Pearson correlation and Principal Component Analysis (PCA) were used. Multiple 
approaches were used to identify differentially expressed genes (DEGs) between different groups, including 
DESeq257, edgeR58 with or without removing unwanted variations (RUV)59. Genes with a Benjamini-Hochberg 
(BH) multiple testing adjusted P value of <0.05 were defined as differentially expressed.
Western blot analysis. Western blots were carried out as previously described60. Details of the primary 
antibodies (anti-TRPM1, -Myc1, and -ACTB antibodies) are shown in Supplementary Table 2. Despite multi-
ple attempts with varying conditions, Western blot using the anti-LRIT3 antibody was unsuccessful resulting 
in non-specific reactions with the canine samples. We therefore chose Myc-tags for the identification of LRIT3 
products in vitro. Briefly, retinal or cell lysates were quantitated using the BCA Protein Assay Kit (Thermo Fisher 
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Scientific, Waltham, MA). Experiments were done in triplicate with 30 μg of protein loaded per lane. The immu-
noblot was scanned on the Odyssey Fc Dual-Mode Imaging System (LI-COR, Lincoln, NE) and normalized 
against β-actin using the LI-COR Image Studio Software (LI-COR). For each sample, the average of the three 
β-actin-normalized values per each antibody was compared with that of the corresponding normalized and aver-
aged value of the WT sample and expressed as fold-changes. Statistical significance was calculated by an unpaired 
t-test using GraphPad (GraphPad Software, San Diego, CA).
Retinal histology, immunohistochemistry (iHc), and electron microscopy. Retinal cryo-
sections from CSNB affected (two females; 13 and 25 mon), carrier (two females; 13 and 25 mon), and three 
age-matched WT control animals were analyzed as described previously37. The antibodies used in this study are 
listed in Supplementary Table 2. Note that the epitope sequence for the commercial anti-LRIT3 antibody used 
(#HPA013454, Sigma-Aldrich, St. Louis, MO) spanned the mutation site. This resulted in only the first 52 amino 
acids of the epitope being present in the mutant LRIT3 whereas the full 141 amino acid epitope sequence was 
present in the WT canine LRIT3. Immunolabelled slides were examined with a Nikon A1R confocal microscope 
(Nikon Instruments Inc., Melville, NY) at 60x and 100x, and digital images were captured and processed using 
the NIS Elements software (Nikon Instruments Inc., Melville, NY). The number of anti-LRIT3 labelled puncta 
in the outer plexiform layer (OPL) in an area equidistant from the optic nerve edge and the ora ciliaris retinae 
were counted in the respective samples following image capture at 60x resolution in a confocal microscope. The 
mean of the total numbers of LRIT3 puncta was calculated and compared among the different LRIT3 genotypes. 
Ultrastructure of the cone pedicles and BCs were imaged by transmission electron microscopy (TEM) with a JEM 
1010 electron microscope (JEOL USA, Inc., Peabody, MA) fitted with a Hamamatsu digital camera (Hamamatsu 
Photonics, Bridgewater, NJ) and AMT Advantage image capture software (Advanced Microscopy Techniques, 
Woburn, MA). The epoxy resin-embedded samples for TEM had been prepared for the previous study37. 
Statistical analysis of the distribution of the contact elements (i.e. triads and diads) for both rods and cones 
between WT and CSNB retinas was done by two-tailed Chi-square test with Yates correction using GraphPad 
(GraphPad Software, San Diego, CA).
DNA constructs, cell transfection, protein analysis and localization of LRIT3. Retinal RNA 
was extracted from CSNB-affected and WT canine retinas and cDNA was generated by reverse transcrip-
tion using SuperScript IV VILO Master Mix (Thermo Fisher Scientific, Waltham, MA). Full-length canine LRIT3 
was cloned into the pKMyc vector (Addgene, Cambridge, MA)61 for each cDNA sample to create N-terminal 
Myc-tagged mutant and WT LRIT3 constructs. Since the transcript cloned from a WT canine retina had two 
SNVs that differed from the CanFam3.1 reference genome at codons 561 and 1271 that altered the amino acids 
which were relatively well conserved in the reference genome, QuikChange II XL Site-Directed Mutagenesis kit 
(Agilent, Santa Clara, CA) was used to introduce the base changes at the two positions. African green monkey 
kidney fibroblast-like cell line (COS1; ATCC, Manassas, VA; cat. #CRL-1650; lot #59102713) and mouse cone 
photoreceptor-like cell line (661 W; purchased from Dr. Muayyad Al-Ubaidi, University of Houston) were grown 
to 80% confluency in DMEM supplemented with 10% FBS and transfected using Lipofectamine 3000 (Invitrogen, 
Carlsbad, CA) as per manufacturer’s instructions. Forty-eight hours post-transfection, cells with either the empty 
vector, mutant or WT Myc-tagged LRIT3 were harvested, proteins extracted using RIPA buffer with 1% pro-
tease and phosphatase inhibitor cocktail (Thermo Fisher Scientific, Waltham, MA), and run in a Western blot as 
detailed above. For immunocytochemistry, 48 hours post-transfected cells grown on poly D-lysine treated cover-
slips were fixed in 4% paraformaldehyde and permeabilised using 0.2% Triton X-100. The cells were then blocked 
for 15 min with 5% BSA and 2.5% fish gelatin prepared in PBS-T (PBS containing 0.1% Tween20). After washing, 
the cells were labelled with the appropriate antibodies for 1 hour following the manufacturer’s dilution instruc-
tions, washed and then labelled with an Alexa dye-tagged secondary antibody (Alexa Fluor Dyes, Molecular 
Probes, Invitrogen, Carlsbad, CA) at 1:200 dilution. The nuclei were stained with DAPI. The cells were mounted 
using Gelvatol mounting medium (Sigma Aldrich, St. Louis, MO), and imaged by confocal microscopy (Nikon, 
Instruments Inc., Melville, NY).
Data Availability
The whole-genome sequencing datasets generated and analysed during the current study are available in the 
European Nucleotide Archive (links to datasets: https://www.ebi.ac.uk/ena/data/view/ERS3011607; https://www.
ebi.ac.uk/ena/data/view/ERS3011608; https://www.ebi.ac.uk/ena/data/view/ERS3011609; https://www.ebi.ac.uk/
ena/data/view/ERS3011610). All data generated or analysed during this study are included in this published arti-
cle (and its Supplementary Information files).
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